Targeting the Interleukin-5 Pathway for Treatment of Eosinophilic Conditions Other than Asthma
Author:
Funder
Fonds De La Recherche Scientifique - FNRS
Publisher
Frontiers Media SA
Subject
General Medicine
Reference117 articles.
1. Transcription factors in eosinophil development and as therapeutic targets;Fulkerson;Front Med,2017
2. Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo;Yu;J Exp Med,2002
3. Defining a link with asthma in mice congenitally deficient in eosinophils;Lee;Science,2004
4. Molecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptor;Molfino;Clin Exp Allergy,2012
5. The eosinophil;Rothenberg;Annu Rev Immunol,2006
Cited by 149 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Real-World Effectiveness of Mepolizumab in Severe Asthma: Results from the Multi-country, Self-controlled Nucala Effectiveness Study (NEST);Advances in Therapy;2024-08-31
2. Single-cell proteomics and transcriptomics capture eosinophil development and identify the role of IL-5 in their lineage transit amplification;Immunity;2024-07
3. TH2 cell compensatory effect following benralizumab treatment for eosinophilic gastritis;Journal of Allergy and Clinical Immunology;2024-07
4. Real-Life Evidence of Mepolizumab Treatment in Chronic Rhinosinusitis with Nasal Polyps: A Multicentric Study;Journal of Clinical Medicine;2024-06-18
5. Eosinophils in Oral Disease: A Narrative Review;International Journal of Molecular Sciences;2024-04-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3